Q32 Bio (QTTB) Other Non-Current Liabilities (2023 - 2025)

Q32 Bio has reported Other Non-Current Liabilities for 3 years, with the latest figure at $55.0 million in Q3 2025.

• For the quarter ending Q3 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $55.0 million; the trailing twelve-month figure through Sep 2025 stood at $55.0 million (changed 0.0% YoY), and the FY2024 full-year result was $55.0 million, changed 0.0% from the prior year.
• Other Non-Current Liabilities for Q3 2025 stood at $55.0 million, roughly flat from $55.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $55.1 million in Q1 2024, with the low at $55.0 million in Q4 2023.
• Average Other Non-Current Liabilities over 3 years is $55.0 million, with a median of $55.0 million recorded in 2023.
• Year-over-year, Other Non-Current Liabilities changed 0.0% in 2024 and decreased 0.21% in 2025.
• Tracing QTTB's Other Non-Current Liabilities over 3 years: stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $55.0 million (Q3 2025), $55.0 million (Q2 2025), and $55.0 million (Q1 2025), per Business Quant data.

Peer Comparison